NIH halts clinical trial of hydroxychloroquine
, study not available yet, Jun 2020
HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.0000000001 from 424 studies, used in 59 countries.
No treatment is 100% effective.
Protocols combine treatments.
NIH halts late stage trial reporting no harm and no benefit. 470 patients.
NIH et al., 19 Jun 2020, preprint, 1 author.
Late treatment
is less effective
is less effective
